Pitt Study Finds New mRNA Vaccine is More Effective and Less Costly to Develop
On Jun. 3, 2025, researchers at University of Pittsburgh School of Public Health and the Pennsylvania State University.A…
Bird-flu vaccine for cattle aces early test
On May, 20, 2025, a team of scientists has developed a fresh approach: the first mRNA bird-flu vaccine…
World’s first patient treated with personalized CRISPR gene editing therapy at Children’s Hospital of Philadelphia
On May 15, 2025, a team at Children’s Hospital of Philadelphia (CHOP) and Penn Medicine announced that a…
White-tailed deer found to be huge reservoir of SARS-CoV-2 infection
On Nov. 8, 2020, research from the U.S. had shown that white-tailed deer were being infected with SARS-CoV-2,…
Penn Medicine researchers received $97 million grant from the NIH to study traumatic brain injuries and neurodegeneration
On Oct. 24, 2019, Penn Medicine researchers received $9.7 million grant from the NIH to study traumatic brain…
Penn Medicine developed gene therapy to treat Duchenne muscular dystrophy (DMD
On Oct. 7, 2019, Penn Medicine announced it had developed gene therapy to treat Duchenne muscular dystrophy (DMD)…
Penn Medicine received $22 million from NIH HEAL Initiative to combat the national opioid crisis
On Oct. 4, 2019, Penn Medicine announced they had received $22 Million from National Institutes of Health’s (NIH)…
UPenn completed exclusive R&D alliance with Novartis
On Sept. 12, 2019, UPenn completed its exclusive, 7-year research and development alliance with Novartis, that spawned the…
Penn received a $12 million grant to study the connection between cellular therapies and new methods of radiation therapy
On Jun. 3, 2019, the University of Pennsylvania (Penn) announced it had received a $12 million grant from…
The National Cancer Institute awarded a $10.7 million grant to Abramson Cancer Center to study CAR T cells in solid tumors
On Oct. 22, 2018, the National Cancer Institute (NC) awarded a $10.7 million five year grant to Abramson…
First wine making was discovered
On. Nov. 13, 2017, research by Dr. Patrick McGovern, Director of the Biomolecular Archaeology Laboratory at the University…
University of Pennsylvania announced $1.5 billion Hospital Pavilion
On May 3, 2017, the University of Pennsylvania announced plans to build a $1.5 billion new hospital on…
The Parker Institute for Cancer Immunotherapy was founded
On Apr. 13, 2016, the Parker Institute for Cancer Immunotherapy was created with a $250 million grant from…
Bioject Medical Technologies was acquired by Inovio Pharmaceuticals
On Mar. 14, 2016, Inovio Pharmaceuticals announced an agreement to acquire all of Bioject Medical Technologies’ assets including…
Korff estate gifted $5 million to advance prostate cancer research and treatments in Nebraska
On Nov. 18, 2015, the estate of Glenn Korff gifted $5 million to the Fred & Pamela Buffett…
FDA approved quadrivalent formulation of Fluzone Intradermal inactivated influenza vaccine
On Dec. 12, 2014, Sanofi Pasteur announced the U.S. Food and Drug Administration (FDA) had approved the supplemental…
DNA was isolated from the deadly 1849 cholera outbreak in Philadelphia
On Jan. 9, 2014, DNA was isolated from a 165-year-old intestine of a cholera victim from Philadelphia – …
Matrical Bioscience acquired by Brooks Automation for $10 million
On Jul. 23, 2013, Matrical Bioscience announced it has had been acquired by Chelmsford, Massachusetts-based Brooks Automation for…
The Center for Personalized Diagnostics (CPD) was established at UPenn
In Feb. 2013, the Center for Personalized Diagnostics (CPD) was established at UPenn for researching genomic and therapeutic…
The Basser Center for BRCA was established at Penn Medicine’s Abramson Cancer Center
In 2012, the Basser Center for BRCA was established at Penn Medicine’s Abramson Cancer Center to establish a…
First international collaboration on Alzheimer’s disease genetics was launched
On Jan. 31, 2011, the first international collaboration on Alzheimer’s disease genetics was launched. The International Genomics of…
CDC published updated recommendation for meningococcal vaccination of at-risk children age 2-10 years in MMWR
On Oct. 17, 2007, the Food and Drug Administration (FDA) approved quadrivalent meningococcal conjugate vaccine (MCV4) (Menactra®, Sanofi…
HHS awarded $132.5 million to Sanofi Pasteur and MedImmune over five years to retrofit existing domestic vaccine manufacturing facilities
On Jun. 14, 2007, the U.D. of Health and Human Services (HHS) awarded $132.5 million to Sanofi Pasteur…
FDA approved an accelerated dosing schedule for Twinrix (hepatitis A and B vaccine)
On Mar. 28, 2007, the FDA announced that GlaxoSmithKline (King of Prussia, Pennsylvania) received approval for an alternate…
The CDC responded to a multi-state outbreak of E coli infections
On Dec. 14, 2006, the U.S. Centers for Disease Control and Prevention (CDC) reported a multi-state outbreak of…
HHS awarded a contract for $97 million to Sanofi Pasteur to develop cell culture-based influenza vaccines for the U.S.
On Apr. 1, 2005, Sanofi pasteur was awarded a five-year $97 million contract from the U.S. Department of…
Contracts awarded to Aventis Pasteur and Chiron to develop vaccine against H5N1 avian influenza virus
On May 27, 2004, the National Institute of Allergy and Infectious Diseases (NIAID) announced it had awarded contracts…
Penn Medicine’s Cancer Center was renamed the Abramson Cancer Center of the University of Pennsylvania
In 2002, the Penn Medicine’s Cancer Center was renamed the Abramson Cancer Center of the University of Pennsylvania…
ACIP voted to withdraw their recommendation for rotavirus vaccine
On Oct. 22, 1999, the Advisory Committee on Immunization Practices (ACIP), after a review of scientific data from…
Wyeth Lederle Vaccines voluntarily withdrew Rotashield from the market
On Oct. 15, 1999, Wyeth-Lederle Vaccines announced that it was withdrawing the Rotashield vaccine from the market and…